Courtesy of Benzinga.
In a report published Monday, Morgan Stanley analyst Steve Beuchaw reiterated an Underweight rating on Varian Medical Systems, Inc. (NYSE: VAR), but removed the $76.00 price target.
In the report, Morgan Stanley noted, “ASTRO’s reimbursement update confirmed that a new radiation oncology rate structure will bundle codes and stratify rates by case complexity. We continue to see downside to payment levels and pressure ahead for the US market.”
Varian Medical Systems closed on Friday at $85.33.
Latest Ratings for VAR
Date | Firm | Action | From | To |
---|---|---|---|---|
Jul 2014 | JP Morgan | Maintains | Overweight | |
Jul 2014 | Jefferies | Maintains | Buy | |
Jun 2014 | ISI Group | Initiates Coverage on | Neutral |
View More Analyst Ratings for VAR
View the Latest Analyst Ratings
Posted-In: Morgan Stanley Steve BeuchawAnalyst Color Price Target Analyst Ratings